Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / chugai pharmaceutical steady outlook but pipeline vi

CHGCF - Chugai Pharmaceutical: Steady Outlook But Pipeline Visibility Limited

Chugai Pharmaceutical
  • Chugai Pharmaceutical experienced unexpected demand for the drug Actemra during the pandemic, but sales appear to have peaked in FY12/2020.
  • New releases such as Hemlibra should begin to scale in FY12/2021, together with distribution sales of Roche's Tecentriq.
  • The company has a stable outlook for the medium term, but with limited visibility over the development pipeline, we are neutral on the shares.

For further details see:

Chugai Pharmaceutical: Steady Outlook But Pipeline Visibility Limited
Stock Information
Company Name: Chugai Pharmaceutical
Stock Symbol: CHGCF
Market: OTC
Menu
CHGCF CHGCF Quote CHGCF Short CHGCF News CHGCF Articles CHGCF Message Board
Get CHGCF Alerts

News, Short Squeeze, Breakout and More Instantly...